{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:15:20Z","timestamp":1788869720774,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58188-5","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:55:40Z","timestamp":1781844940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allicin-loaded soluplus polymeric micelles differentially modulate doxorubicin response in adenocarcinoma and myocardial cell models"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-3254","authenticated-orcid":false,"given":"Khaldoun J.","family":"Al-Hadid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walhan","family":"Alshaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baidaa","family":"AlQuaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan Ziad","family":"Al-Momany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nowar","family":"Alsarayreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana A.","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem","family":"Alsheleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"58188_CR1","doi-asserted-by":"publisher","first-page":"e1001786","DOI":"10.1371\/journal.pmed.1001786","volume":"12","author":"EA Mroz","year":"2015","unstructured":"Mroz, E. A., Tward, A. M., Hammon, R. J., Ren, Y. & Rocco, J. W. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med. 12, e1001786 (2015).","journal-title":"PLoS Med."},{"key":"58188_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","volume":"35","author":"M Nikolaou","year":"2018","unstructured":"Nikolaou, M., Pavlopoulou, A., Georgakilas, A. G. & Kyrodimos, E. The challenge of drug resistance in cancer treatment: a current overview. Clin. Exp. Metastasis. 35, 309\u2013318 (2018).","journal-title":"Clin. Exp. Metastasis"},{"key":"58188_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/life12010048","volume":"12","author":"D Basak","year":"2021","unstructured":"Basak, D., Arrighi, S., Darwiche, Y. & Deb, S. Comparison of anticancer drug toxicities: paradigm shift in adverse effect profile. Life 12, 48 (2021).","journal-title":"Life"},{"key":"58188_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/ph14090835","volume":"14","author":"V Gyanani","year":"2021","unstructured":"Gyanani, V., Haley, J. C. & Goswami, R. Challenges of current anticancer treatment approaches with focus on liposomal drug delivery systems. Pharmaceuticals 14, 835 (2021).","journal-title":"Pharmaceuticals"},{"key":"58188_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/156720110791011783","volume":"7","author":"P Utreja","year":"2010","unstructured":"Utreja, P., Jain, S. & Tiwary, K. Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospects. Curr. Drug Deliv. 7, 152\u2013161 (2010).","journal-title":"Curr. Drug Deliv"},{"key":"58188_CR6","first-page":"477","volume":"8","author":"S Vijayaraghavalu","year":"2007","unstructured":"Vijayaraghavalu, S., Raghavan, D. & Labhasetwar, V. Nanoparticles for delivery of chemotherapeutic agents to tumors. Curr. Opin. Investig Drugs. 8, 477\u2013484 (2007).","journal-title":"Curr. Opin. Investig Drugs"},{"key":"58188_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mco2.55","volume":"2","author":"YP Liu","year":"2021","unstructured":"Liu, Y. P. et al. Molecular mechanisms of chemo-and radiotherapy resistance and the potential implications for cancer treatment. MedComm 2, 315\u2013340 (2021).","journal-title":"MedComm"},{"key":"58188_CR8","doi-asserted-by":"publisher","first-page":"59950","DOI":"10.18632\/oncotarget.19048","volume":"8","author":"HC Zheng","year":"2017","unstructured":"Zheng, H. C. The molecular mechanisms of chemoresistance in cancers. Oncotarget 8, 59950 (2017).","journal-title":"Oncotarget"},{"key":"58188_CR9","doi-asserted-by":"publisher","first-page":"753766","DOI":"10.3389\/fnano.2021.753766","volume":"3","author":"CM L\u00f3pez Mendoza","year":"2022","unstructured":"L\u00f3pez Mendoza, C. M. Alc\u00e1ntara Quintana, L. E. Smart drug delivery strategies for cancer therapy. Front. Nanotechnol. 3, 753766 (2022).","journal-title":"Front. Nanotechnol"},{"key":"58188_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.18433\/J30C7D","volume":"14","author":"M Chidambaram","year":"2011","unstructured":"Chidambaram, M., Manavalan, R. & Kathiresan, K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 14, 67\u201377 (2011).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"58188_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang, M., Lu, J. J. & Ding, J. Natural products in cancer therapy: past, present and future. Nat. Prod. Bioprospect. 11, 5\u201313 (2021).","journal-title":"Nat. Prod. Bioprospect"},{"key":"58188_CR12","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"10","author":"AS Choudhari","year":"2020","unstructured":"Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P. & Prakash, O. Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front. Pharmacol. 10, 1614 (2020).","journal-title":"Front. Pharmacol."},{"key":"58188_CR13","first-page":"1","volume":"71","author":"WH Talib","year":"2024","unstructured":"Talib, W. H. et al. Anticancer potential of garlic bioactive constituents: Allicin, Z-ajoene, and organosulfur compounds. Pharmacia 71, 1\u201323 (2024).","journal-title":"Pharmacia"},{"key":"58188_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/molecules29061320","volume":"29","author":"WH Talib","year":"2024","unstructured":"Talib, W. H. et al. Allicin and cancer hallmarks. Molecules 29, 1320 (2024).","journal-title":"Molecules"},{"key":"58188_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12032-024-02459-6","volume":"41","author":"S Bhuker","year":"2024","unstructured":"Bhuker, S. et al. Allicin: a promising modulator of apoptosis and survival signaling in cancer. Med. Oncol. 41, 210 (2024).","journal-title":"Med. Oncol."},{"key":"58188_CR16","doi-asserted-by":"publisher","first-page":"e0248878","DOI":"10.1371\/journal.pone.0248878","volume":"16","author":"P Jansk\u00e1","year":"2021","unstructured":"Jansk\u00e1, P. et al. Effect of physicochemical parameters on the stability and activity of garlic alliinase and its use for in-situ allicin synthesis. PloS one. 16, e0248878 (2021).","journal-title":"PloS one"},{"key":"58188_CR17","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s13346-022-01182-x","volume":"12","author":"R Pignatello","year":"2022","unstructured":"Pignatello, R. et al. Soluplus\u00ae polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 12, 1991\u20132006 (2022).","journal-title":"Drug Deliv Transl Res."},{"key":"58188_CR18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/nu10070812","volume":"10","author":"LD Lawson","year":"2018","unstructured":"Lawson, L. D. & Hunsaker, S. M. Allicin bioavailability and bioequivalence from garlic supplements and garlic foods. Nutrients 10, 812 (2018).","journal-title":"Nutrients"},{"key":"58188_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox6010001","volume":"6","author":"MC 19 Gruhlke","year":"2016","unstructured":"19 Gruhlke, M. C., Nicco, C., Batteux, F. & Slusarenko, A. J. The effects of allicin, a reactive sulfur species from garlic, on a selection of mammalian cell lines. Antioxidants 6, 1 (2016).","journal-title":"Antioxidants"},{"key":"58188_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00210-023-02675-3","volume":"397","author":"R Bala","year":"2024","unstructured":"Bala, R. et al. Revitalizing allicin for cancer therapy: advances in formulation strategies to enhance bioavailability, stability, and clinical efficacy. Naunyn Schmiedebergs Arch. Pharmacol. 397, 703\u2013724 (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"58188_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","volume":"24","author":"P Kumari","year":"2016","unstructured":"Kumari, P., Ghosh, B. & Biswas, S. Nanocarriers for cancer-targeted drug delivery. J. Drug Target. 24, 179\u2013191 (2016).","journal-title":"J. Drug Target."},{"key":"58188_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.pharmthera.2006.05.006","volume":"112","author":"N Nishiyama","year":"2006","unstructured":"Nishiyama, N. & Kataoka, K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 112, 630\u2013648 (2006).","journal-title":"Pharmacol. Ther."},{"key":"58188_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/13543776.17.7.819","volume":"17","author":"L Qiu","year":"2007","unstructured":"Qiu, L., Zheng, C., Jin, Y. & Zhu, K. Polymeric micelles as nanocarriers for drug delivery. Expert Opin. Ther. Pat. 17, 819\u2013830 (2007).","journal-title":"Expert Opin. Ther. Pat."},{"key":"58188_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4155\/tde-2020-0008","volume":"11","author":"N Majumder","year":"2020","unstructured":"Majumder, N., Das, G., Das, S. & N. & K. Polymeric micelles for anticancer drug delivery. Ther. Deliv. 11, 613\u2013635 (2020).","journal-title":"Ther. Deliv"},{"key":"58188_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.procbio.2022.05.027","volume":"120","author":"S Bhattacharya","year":"2022","unstructured":"Bhattacharya, S., Sen, D. & Bhattacharjee, C. Strategic development to stabilize bioactive diallyl thiosulfinate by pH responsive non ionic micelle carrier system. Process. Biochem. 120, 64\u201373 (2022).","journal-title":"Process. Biochem."},{"key":"58188_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pharmaceutics18010011","volume":"18","author":"AB Uzakova","year":"2025","unstructured":"Uzakova, A. B., Yergaliyeva, E. M., Yerlanuly, A. & Mukatayeva, Z. S. A Systematic Review of Advanced Drug Delivery Systems: Engineering Strategies, Barrier Penetration, and Clinical Progress (2016\u2013April 2025). Pharmaceutics 18, 11 (2025).","journal-title":"Pharmaceutics"},{"key":"58188_CR27","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/ijms26041499","volume":"26","author":"N Guembe-Michel","year":"2025","unstructured":"Guembe-Michel, N., Nguewa, P. & Gonz\u00e1lez-Gaitano, G. Soluplus\u00ae-based pharmaceutical formulations: recent advances in drug delivery and biomedical applications. Int. J. Mol. Sci. 26, 1499 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"58188_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.biopha.2014.12.028","volume":"69","author":"X Jin","year":"2015","unstructured":"Jin, X., Zhou, B., Xue, L. & San, W. Soluplus\u00ae micelles as a potential drug delivery system for reversal of resistant tumor. Biomed. Pharmacother. 69, 388\u2013395 (2015).","journal-title":"Biomed. Pharmacother"},{"key":"58188_CR29","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1016\/j.xphs.2016.03.006","volume":"105","author":"F Alvarez-Rivera","year":"2016","unstructured":"Alvarez-Rivera, F., Fern\u00e1ndez-Villanueva, D. & Concheiro, A. Alvarez-Lorenzo, C. \u03b1-Lipoic acid in Soluplus\u00ae polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases. J. Pharm. Sci. 105, 2855\u20132863 (2016).","journal-title":"J. Pharm. Sci."},{"key":"58188_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11655-016-2523-0","volume":"23","author":"L Ma","year":"2017","unstructured":"Ma, L. et al. Allicin improves cardiac function by protecting against apoptosis in rat model of myocardial infarction. Chin. J. Integr. Med. 23, 589\u2013597 (2017).","journal-title":"Chin. J. Integr. Med."},{"key":"58188_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ptr.4796","volume":"27","author":"JYY Chan","year":"2013","unstructured":"Chan, J. Y. Y., Yuen, A. C. Y., Chan, R. Y. K. & Chan, S. W. A review of the cardiovascular benefits and antioxidant properties of allicin. Phytother Res. 27, 637\u2013646 (2013).","journal-title":"Phytother Res."},{"key":"58188_CR32","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1039\/b611506c","volume":"4","author":"Y Okada","year":"2006","unstructured":"Okada, Y., Tanaka, K., Sato, E. & Okajima, H. Kinetic and mechanistic studies of allicin as an antioxidant. Org. Biomol. Chem. 4, 4113\u20134117 (2006).","journal-title":"Org. Biomol. Chem."},{"key":"58188_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1039\/D1BM01802G","volume":"10","author":"R Liang","year":"2022","unstructured":"Liang, R., Wong, K. H., Yang, Y., Duan, Y. & Chen, M. ROS-responsive dexamethasone micelles normalize the tumor microenvironment enhancing hypericin in cancer photodynamic therapy. Biomaterials Sci. 10, 1018\u20131025. https:\/\/doi.org\/10.1039\/D1BM01802G (2022).","journal-title":"Biomaterials Sci."},{"key":"58188_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/molecules30071549","volume":"30","author":"W Alshaer","year":"2025","unstructured":"Alshaer, W. et al. Remote Co-Loading of Doxorubicin and Hydralazine into PEGylated Liposomes: In Vitro Anti-Proliferative Effect Against Breast Cancer. Molecules 30, 1549 (2025).","journal-title":"Molecules"},{"key":"58188_CR35","doi-asserted-by":"publisher","first-page":"2119020","DOI":"10.1080\/21645515.2022.2119020","volume":"18","author":"Q Yin","year":"2022","unstructured":"Yin, Q., Wang, Y., Xiang, Y. & Xu, F. Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses. Hum. Vaccin Immunother. 18, 2119020 (2022).","journal-title":"Hum. Vaccin Immunother"},{"key":"58188_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/acs.molpharmaceut.1c00704","volume":"19","author":"L Li","year":"2021","unstructured":"Li, L. et al. Nanoparticle\/nanocarrier formulation as an antigen: the immunogenicity and antigenicity of itself. Mol. Pharm. 19, 148\u2013159 (2021).","journal-title":"Mol. Pharm."},{"key":"58188_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1039\/C7PY01603D","volume":"9","author":"J Zhao","year":"2018","unstructured":"Zhao, J. & Stenzel, M. H. Entry of nanoparticles into cells: The importance of nanoparticle properties. Polym. Chem. 9, 259\u2013272 (2018).","journal-title":"Polym. Chem."},{"key":"58188_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28\u201351 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"58188_CR39","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1021\/jf8000907","volume":"56","author":"H Fujisawa","year":"2008","unstructured":"Fujisawa, H. et al. Biological and chemical stability of garlic-derived allicin. J. Agric. Food Chem. 56, 4229\u20134235 (2008).","journal-title":"J. Agric. Food Chem."},{"key":"58188_CR40","doi-asserted-by":"publisher","first-page":"12591","DOI":"10.3390\/molecules190812591","volume":"19","author":"J 40 Borlinghaus","year":"2014","unstructured":"40 Borlinghaus, J., Albrecht, F., Gruhlke, M. C., Nwachukwu, I. D. & Slusarenko, A. J. Allicin: chemistry and biological properties. Molecules 19, 12591\u201312618 (2014).","journal-title":"Molecules"},{"key":"58188_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/2468187309666190314152451","volume":"9","author":"R Pignatello","year":"2019","unstructured":"Pignatello, R. & Corsaro, R. Polymeric nanomicelles of Soluplus\u00ae as a strategy for enhancing the solubility, bioavailability and efficacy of poorly soluble active compounds. Curr. Nanomed. 9, 184\u2013197 (2019).","journal-title":"Curr. Nanomed."},{"key":"58188_CR42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/1556-276X-9-684","volume":"9","author":"L Dian","year":"2014","unstructured":"Dian, L. et al. Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res. Lett. 9, 684. https:\/\/doi.org\/10.1186\/1556-276X-9-684 (2014).","journal-title":"Nanoscale Res. Lett."},{"key":"58188_CR43","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.3390\/ijms23169382","volume":"23","author":"MR Ozturk","year":"2022","unstructured":"Ozturk, M. R. et al. Drug-loaded polymeric micelles based on smart biocompatible graft copolymers with potential applications for the treatment of glaucoma. Int. J. Mol. Sci. 23, 9382 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"58188_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijpharm.2012.05.020","volume":"434","author":"Y Zambito","year":"2012","unstructured":"Zambito, Y., Pedreschi, E. & Di Colo, G. Is dialysis a reliable method for studying drug release from nanoparticulate systems?\u2014A case study. Int. J. Pharm. 434, 28\u201334 (2012).","journal-title":"Int. J. Pharm."},{"key":"58188_CR45","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/pharmaceutics13122007","volume":"13","author":"MP Mast","year":"2021","unstructured":"Mast, M. P., Modh, H., Knoll, J., Fecioru, E. & Wacker, M. G. An Update to Dialysis-Based Drug Release Testing\u2014Data Analysis and Validation Using the Pharma Test Dispersion Releaser. Pharmaceutics 13, 2007 (2021).","journal-title":"Pharmaceutics"},{"key":"58188_CR46","doi-asserted-by":"publisher","first-page":"16495","DOI":"10.1021\/acs.jpcc.9b00913","volume":"123","author":"HT Phan","year":"2019","unstructured":"Phan, H. T. & Haes, A. J. What does nanoparticle stability mean? J. Phys. Chem. C. 123, 16495\u201316507 (2019).","journal-title":"J. Phys. Chem. C"},{"key":"58188_CR47","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1021\/acs.chemrev.7b00208","volume":"118","author":"L Xu","year":"2018","unstructured":"Xu, L., Liang, H. W., Yang, Y. & Yu, S. H. Stability and reactivity: positive and negative aspects for nanoparticle processing. Chem. Rev. 118, 3209\u20133250 (2018).","journal-title":"Chem. Rev."},{"key":"58188_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2298\/HEMIND091111003I","volume":"64","author":"DP Ili\u0107","year":"2010","unstructured":"Ili\u0107, D. P., Nikoli\u0107, V. D., Nikoli\u0107, L. B., Stankovi\u0107, M. Z. & Stanojevi\u0107, L. P. Thermal degradation, antioxidant and antimicrobial activity of the synthesized allicin and allicin incorporated in gel. Hem Ind. 64, 85\u201391 (2010).","journal-title":"Hem Ind."},{"key":"58188_CR49","first-page":"183","volume":"2","author":"H Lin","year":"2015","unstructured":"Lin, H., Chi, Y., Huang, Y., Kao, C. & Lin, S. DSC-FTIR combined approaches used to simultaneously prepare\/determine the amorphous solid dispersions of indomethacin\/Soluplus in real-time. EC Pharm. Sci. 2, 183\u2013193 (2015).","journal-title":"EC Pharm. Sci."},{"key":"58188_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40959-016-0012-4","volume":"2","author":"A De Angelis","year":"2016","unstructured":"De Angelis, A. et al. Doxorubicin cardiotoxicity and target cells: a broader perspective. Cardio-Oncology 2, 2 (2016).","journal-title":"Cardio-Oncology"},{"key":"58188_CR51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12012-022-09721-1","volume":"22","author":"M Sheibani","year":"2022","unstructured":"Sheibani, M. et al. Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches. Cardiovasc. Toxicol. 22, 292\u2013310 (2022).","journal-title":"Cardiovasc. Toxicol."},{"key":"58188_CR52","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/ijms20071606","volume":"20","author":"A Perez-Sanchez","year":"2019","unstructured":"Perez-Sanchez, A. et al. Intestinal permeability study of clinically relevant formulations of silibinin in Caco-2 cell monolayers. Int. J. Mol. Sci. 20, 1606 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"58188_CR53","doi-asserted-by":"publisher","first-page":"887598","DOI":"10.3389\/fphar.2022.887598","volume":"13","author":"Q Tao","year":"2022","unstructured":"Tao, Q. et al. Investigation of the uptake and transport of aspirin eugenol ester in the caco-2 cell model. Front. Pharmacol. 13, 887598 (2022).","journal-title":"Front. Pharmacol."},{"key":"58188_CR54","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/jpp\/rgab006","volume":"73","author":"M Ossama","year":"2021","unstructured":"Ossama, M., Hathout, R. M., Attia, D. A. & Mortada, N. D. Augmented cytotoxicity using the physical adsorption of Poloxamer 188 on allicin-loaded gelatin nanoparticles. J. Pharm. Pharmacol. 73, 664\u2013672 (2021).","journal-title":"J. Pharm. Pharmacol."},{"key":"58188_CR55","doi-asserted-by":"publisher","first-page":"12894","DOI":"10.1021\/acs.jcim.5c02447","volume":"65","author":"Y Hao","year":"2025","unstructured":"Hao, Y. et al. Computational Lipidomics Reveals Environment-Specific Membrane Remodeling in Prostate Cancer. J. Chem. Inf. Model. 65, 12894\u201312904 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"58188_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0005-2736(99)00174-1","volume":"1463","author":"T Miron","year":"2000","unstructured":"Miron, T., Rabinkov, A., Mirelman, D., Wilchek, M. & Weiner, L. The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim. Biophys. Acta Biomembr. 1463, 20\u201330 (2000).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"58188_CR57","doi-asserted-by":"crossref","unstructured":"Adjei, I. M., Sharma, B. & Labhasetwar, V. Nanoparticles: cellular uptake and cytotoxicity. Nanomaterial: Impacts Cell. Biol. Med, 73\u201391 (2014).","DOI":"10.1007\/978-94-017-8739-0_5"},{"key":"58188_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/smll.200901158","volume":"6","author":"A Verma","year":"2010","unstructured":"Verma, A. & Stellacci, F. Effect of surface properties on nanoparticle\u2013cell interactions. Small 6, 12\u201321 (2010).","journal-title":"Small"},{"key":"58188_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/etc.2470","volume":"33","author":"K Kettler","year":"2014","unstructured":"Kettler, K., Veltman, K., van De Meent, D., van Wezel, A. & Hendriks, A. J. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ. Toxicol. Chem. 33, 481\u2013492 (2014).","journal-title":"Environ. Toxicol. Chem."},{"key":"58188_CR60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505\u2013515 (2008).","journal-title":"Mol. Pharm."},{"key":"58188_CR61","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","volume":"46","author":"S Behzadi","year":"2017","unstructured":"Behzadi, S. et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46, 4218\u20134244 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"58188_CR62","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi, M. et al. Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions. J. Controlled Release. 332, 312\u2013336. https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.031 (2021). https:\/\/doi.org:.","journal-title":"J. Controlled Release"},{"key":"58188_CR63","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S. & Navik, U. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed. Pharmacother. 139, 111708 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"58188_CR64","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","volume":"34","author":"FS Carvalho","year":"2014","unstructured":"Carvalho, F. S. et al. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med. Res. Rev. 34, 106\u2013135 (2014).","journal-title":"Med. Res. Rev."},{"key":"58188_CR65","doi-asserted-by":"publisher","first-page":"1725943","DOI":"10.3389\/fphar.2025.1725943","volume":"16","author":"M Mojamel","year":"2025","unstructured":"Mojamel, M., Al-Mahbashi, H. & Al-Nabehi, A. Dual therapy with allicin and metformin provides superior cardioprotection against doxorubicin-induced cardiotoxicity in rats compared to monotherapy. Front. Pharmacol. 16, 1725943 (2025).","journal-title":"Front. Pharmacol."},{"key":"58188_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12013-024-01215-x","volume":"82","author":"G Shi","year":"2024","unstructured":"Shi, G. et al. Allicin overcomes doxorubicin resistance of breast cancer cells by targeting the Nrf2 pathway. Cell. Biochem. Biophys. 82, 659\u2013667 (2024).","journal-title":"Cell. Biochem. Biophys."},{"key":"58188_CR67","doi-asserted-by":"crossref","unstructured":"Mohammed, M. O., Muhamad, F. A. & Dyary, H. O. Allicin attenuates doxorubicin-induced testicular and systemic toxicity in rats via antioxidant and anti-apoptotic mechanisms. Reprod Toxicol, 109082 (2025).","DOI":"10.1016\/j.reprotox.2025.109082"},{"key":"58188_CR68","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.lfs.2004.05.040","volume":"76","author":"H Mizutani","year":"2005","unstructured":"Mizutani, H., Tada-Oikawa, S., Hiraku, Y., Kojima, M. & Kawanishi, S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 76, 1439\u20131453 (2005).","journal-title":"Life Sci."},{"key":"58188_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1023\/A:1015976430790","volume":"234","author":"B Kalyanaraman","year":"2002","unstructured":"Kalyanaraman, B. et al. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol. Cell. Biochem. 234, 119\u2013124 (2002).","journal-title":"Mol. Cell. Biochem."},{"key":"58188_CR70","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.3390\/ijms222312827","volume":"22","author":"M Ghasemi","year":"2021","unstructured":"Ghasemi, M., Turnbull, T., Sebastian, S. & Kempson, I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci. 22, 12827 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"58188_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutellingsperger, C. A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184, 39\u201351. https:\/\/doi.org\/10.1016\/0022-1759(95)00072-I (1995).","journal-title":"J. Immunol. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58188-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58188-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:02:29Z","timestamp":1788868949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58188-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58188"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58188-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28053"}}